Focused ultrasound-mediated APOE4 knockdown in mouse brain

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• The apolipoprotein E (APOE) ε4 allele is the primary genetic risk factor for late-onset Alzheimer's disease.
• Therapeutic strategies targeting APOE ε4 aim to reduce neuroinflammation and neurodegeneration.

Purpose of the Study:

• To investigate the efficacy of focused ultrasound (FUS) in delivering gene editing tools for APOE ε4 knockdown.
• To assess the impact of APOE ε4 reduction on Alzheimer's-related biomarkers in a mouse model.

Main Methods:

• Focused ultrasound (FUS) was used to transiently open the blood-brain barrier (BBB) for enhanced delivery of CRISPR-based adeno-associated virus (AAV) vectors.
• AAV vectors were administered intravenously to target the hippocampus for gene editing of humanized APOE ε4 in mice.

Main Results:

• FUS-mediated delivery achieved a 12.6% knockdown of APOE ε4 gene expression in the hippocampus.
• ApoE4 protein levels decreased by over 20%, with significant reductions in astrocyte and microglia markers.
• No gross toxicity was observed post-intervention.

Conclusions:

• Focused ultrasound (FUS) offers a noninvasive, targeted method for gene editing and therapeutic intervention in the brain.
• FUS-mediated APOE ε4 knockdown presents a promising strategy for Alzheimer's disease treatment.
• This approach effectively reduces key Alzheimer's-related genetic and cellular markers.